...
首页> 外文期刊>Journal of cardiac surgery. >Prevalence and procedural outcomes of percutaneous coronary intervention and coronary artery bypass grafting in patients with diabetes and multivessel coronary artery disease.
【24h】

Prevalence and procedural outcomes of percutaneous coronary intervention and coronary artery bypass grafting in patients with diabetes and multivessel coronary artery disease.

机译:糖尿病和多支冠状动脉疾病患者的经皮冠状动脉介入治疗和冠状动脉搭桥术的患病率和手术结局。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Percutaneous coronary intervention (PCI) is used with increasing frequency in patients with diabetes and multivessel disease. This study investigated evolving revascularization strategies in the State of Washington. METHODS: The Clinical Outcomes Assessment Program captures all revascularization in the State of Washington and was used to compare diabetic patients with multivessel disease undergoing first-time revascularization from 1999 to 2007. Categorical variables were compared with the chi-squared test and continuous variables were compared with the student's t-test. Results were risk-adjusted using a logistic regression. RESULTS: A total of 11,602 patients with diabetes and multivessel disease underwent revascularization from 1999 to 2007 and were nearly equally divided between coronary artery bypass grafting (CABG) (51%) and PCI (49%). Patients undergoing CABG had a higher (p < 0.0001) prevalence of congestive heart failure, cerebrovascular disease, peripheral vascular disease, three-vessel coronary artery disease (CAD), and intraaortic balloon pump insertion, but a lower prevalence of female gender, cardiogenic shock, and emergency procedures. Patients undergoing CABG had more (p < 0.0001) three-vessel CAD and more complete revascularization (3.7 vs. 1.5 lesions treated). Short-term risk-adjusted mortality was equivalent. The prevalence of PCI increased from 34.1% in 1999 to 59.4% in 2007. CONCLUSIONS: PCI is applied with increasing frequency to patients with diabetes mellitus (DM) and multivessel disease. PCI is used most commonly in two-vessel CAD or with acute coronary syndromes with more limited and targeted revascularization. CABG is more commonly applied to extensive disease with more complete revascularization. Both the prevalence and percentage of patients undergoing PCI as primary therapy for multivessel disease with DM is increasing. A multidisciplinary approach may be warranted to ensure optimal outcomes.
机译:背景:糖尿病和多支血管疾病患者使用经皮冠状动脉介入治疗(PCI)的频率越来越高。这项研究调查了华盛顿州不断发展的血运重建策略。方法:临床结果评估计划捕获了华盛顿州的所有血运重建,并用于比较1999年至2007年首次进行血运重建的多支血管病变的糖尿病患者。将分类变量与卡方检验进行比较,并比较连续变量用学生的t检验。使用逻辑回归对结果进行风险调整。结果:从1999年至2007年,共有11602名糖尿病和多支血管疾病患者进行了血运重建,冠脉搭桥术(CABG)(51%)和PCI(49%)几乎相等。接受CABG的患者发生充血性心力衰竭,脑血管疾病,周围血管疾病,三支冠状动脉疾病(CAD)和主动脉内球囊泵插入的患病率较高(p <0.0001),但女性,心源性休克的患病率较低,以及紧急程序。接受CABG的患者有更多(p <0.0001)三支血管CAD和更完全的血运重建(治疗的病灶分别为3.7和1.5)。短期风险调整后的死亡率相当。 PCI的患病率从1999年的34.1%上升到2007年的59.4%。结论:PCI被越来越多地应用于糖尿病(DM)和多支血管疾病患者。 PCI最常用于两支血管CAD或急性冠脉综合症,且血运重建的目标更有限。 CABG通常用于具有更完全血运重建的广泛疾病。接受PCI作为DM的多支血管疾病的主要疗法的患者的患病率和百分比都在增加。可能需要采用多学科方法来确保最佳结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号